ABOUT US

What we do

Infimer has developed a breakthrough technology and innovative processes for treating unsorted municipal waste and turning it into a novel thermoplastic composite material – Infimer® – which can be used as a raw material for the plastics industry.

Infimer conducted several production trials with the new technology. The Infimer® product was tested by a large plastics company, and as a result, Infimer received significant orders from that company.

Infimer is now building its first production line in order to supply these orders and future demands.

Infimer invests significant resources to further developing its technology to produce Infimer®, and in addition, leverages its patent pending processes for waste treatment to develop more efficient and economic production processes for  products such as biogas and biofuel .

Our Vision

Infimer aspires to help solve the global waste problem by providing practical and economical solutions which will turn the waste into valuable new materials and products.

Business Overview

Infimer has developed a breakthrough technology and innovative processes for treating unsorted MSW and turning it into a novel thermoplastic composite material – Infimer® – which can be used as a raw material for the plastic industry.

During 2013 and 2014, Infimer conducted several production trials in order to establish and examine the process, characterize the products, validate the technology, and file the corresponding patents for its technology and products.

In a preliminary production trial, the novel polymers were produced, characterized and used by a large plastics company in manufacturing several of its end products.

During a second production trial, several tons of Infimer® were produced in a pilot line, with rented equipment and with equipment manufactured specially for the trial. The trial lasted 10 days, during which the plastics company collected polymer samples directly in order to validate the consistency of the process and the products. The plastics company tested these polymers in their R&D labs, and positive results regarding the consistency of Infimer® were obtained. The plastics company injected 30%-50% of Infimer® mixed with other plastic materials in several factories and produced plastic products which successfully passed all its QA tests. As a result of these trials, a long-term agreement was signed between Infimer and the plastics company. As part of this agreement, Infimer received significant orders, part of which being for immediate supply, and part is stipulated on meeting certain conditions.

The third step was to perform production trials in Europe and get feedback from potential European equipment manufacturers and customers. Two production trials, starting from MSW and ending by producing Infimer®, were conducted in Europe. The MSW treatment and Infimer® production is based on two main processes: (1) waste separation, and (2) production of polymers. Therefore the first process was performed in Germany using local unsorted MSW at a company that specializes in the design and production of separation tanks, grinders and squeezers. The second process, polymer production, was performed in Austria at EREMA, a company that specializes in the design and production of plastic recycling systems. The production of Infimer® was assessed by the TCKT Transfer Center for Plastic Technology in Austria.

 In March 2015, the company completed a merger, by means of a share exchange, with the Tel-Aviv Stock Exchange-listed company, EZ Energy Ltd.
Following completion of the merger, Infimer became a wholly-owned subsidiary of EZ Energy, while Infimer’s shareholders became the controlling shareholders of EZ Energy (71%). On the transaction date, EZ Energy had about US$ 2.4 million in cash. On June 18, 2015, the name of the company was changed from EZ Energy Ltd. to Infimer Ltd.

After completion of the merger, Infimer began designing and building a dedicated production line in order to start supplying the open orders.

In May 2015, Infimer registered in the USA two patents (PCT) and five provisional applications for patents relating to methods of treating municipal waste and producing thermoplastic materials, biogas and biofuels from the treated waste.

Company Structure

Corporate Responsibility

Infimer is committed to behaving ethically and with sensitivity to social, cultural, economic and environmental issues.

As a company that is focused on developing innovative technologies for solving environmental problems and producing green materials, Infimer complies with the most stringent environmental regulations, runs safe and clean production processes, and strives to reduce byproducts and air pollution, minimizing and treating waste water, and applying advanced technologies for bioprocessing waste materials.

Milestones

Brief History of Our Company

June 2013 – Infimer Technologies was established
August 2013 – First production trial
December 2013-January 2014 – Second production trial
January-February 2014 – Production trials with the plastics company
March 2014 – Long-term agreement with the plastics company, received commercial orders, and first production trial in Europe
May 2014 – Provisional application for patents in the USA
September 2014 – Second production trial in Europe
March 2015 – Merger with EZ Energy, raising US $ 2.4 million
May 2015 – Registration of two patents in the USA (PCT) and five new provisional applications for patents